PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Post-LOE

Fosun Pharma

ANDAORALTABLET

Approved

Dec 1987

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE by Fosun Pharma is clinical pharmacology perphenazine in common with all members of the piperazine group of phenothiazine derivatives, perphenazine has greater behavioral potency than phenothiazine derivatives of other groups without a corresponding increase in autonomic, hematologic, or hepatic side effects. First approved in 1987.

Drug data last refreshed 19h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Perphenazine In common with all members of the piperazine group of phenothiazine derivatives, perphenazine has greater behavioral potency than phenothiazine derivatives of other groups without a corresponding increase in autonomic, hematologic, or hepatic side effects.…

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Company

Worked on PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.